Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1993
11/09/1993US5260274 Factor VIII binding domain of von Willebrand Factor
11/09/1993US5260273 Pulmonary surfactant protein and related polypeptide
11/09/1993US5260272 Dnetistry, biofouling
11/09/1993US5260271 Combined with a chelating agent
11/09/1993US5260224 Tissue injury prevention
11/09/1993US5260214 Aureobasidium pullulans which produces antibiotic R106
11/09/1993US5260212 Cloned gene encoding for bacteriocin from Pediococcus acidilactici
11/09/1993US5260210 Blood-brain barrier model
11/09/1993US5260209 Useful for immunization to produce antibodies; diagnosis of genetic defect which causes muscular dystrophy
11/09/1993US5260203 Computer based system determined chemical structure for converting two naturally aggregated but chemically separated light and heavy polpeptide chain into single chain having three dimensional structure
11/09/1993US5260200 Isolated DNA encoding an insulin receptor substrate
11/09/1993US5260074 Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
11/09/1993US5260061 Propionibacteria metabolites inhibit spoilage yeast in foods
11/09/1993US5260060 Fibrinolytic enzymes
11/09/1993US5260059 In an effective amount to reduce intraoccular pressure
11/09/1993US5260057 Method and product for the treatment of gastric disease
11/09/1993US5259951 Passing solution of Factor VIII from human plasma through ion exchange chromatographic column using as equilibrating buffer and eluent high ionic strength saline solution at acid pH; stabilizers
11/09/1993CA2095786A1 Method of stimulating appetite
11/09/1993CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/09/1993CA1324095C Recombinant ricin toxin
11/09/1993CA1324083C Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
11/09/1993CA1324079C Enhanced uptake drug delivery system
11/04/1993DE4225094A1 Compsn. for gene therapy, esp. of viral infections and tumours - comprises anti-sense DNA or RNA inserted into long terminal repeat or transposable element and e.g. virus envelope as carrier
11/03/1993EP0568300A2 Interleukin-4 as a stimulator of bone formation
11/03/1993EP0568200A2 Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections
11/03/1993EP0567816A1 Use of inhibitors of plasminogen activators for treating of inflammations and wounds
11/03/1993EP0567626A1 Amylin agonist peptides and uses therefor
11/03/1993EP0567613A1 Compositions and methods for therapy and prevention of cancer, aids, and anemia
11/03/1993EP0567599A1 Megakaryocyte stimulating factors
11/03/1993EP0567586A1 Use of interleukin-10 in adoptive immunotherapy of cancer.
11/03/1993EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993EP0567581A1 Cell ablation using trans-splicing ribozymes
11/03/1993EP0567578A1 Laminin a chain domain vi polypeptides
11/03/1993EP0567568A1 $i(TRANS)-SPLICING RIBOZYMES
11/03/1993EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567528A1 Depot formulations
11/03/1993EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE
11/03/1993EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine
11/03/1993EP0567508A1 Macroscopically oriented cell adhesion protein for wound treatment
11/03/1993EP0567503A1 Pasteurella haemolytica glycoprotease gene
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0565604A4 Drug delivery system
11/03/1993EP0551286A4 Soluble hirudin conjugates
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/03/1993CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
11/03/1993CN1077960A Hemoregulatory peptides
11/02/1993US5258494 Dimeric protein capable of inducing bone and cartilage formation when implanted, in association with a matrix, in a mammal
11/02/1993US5258493 Cyclic peptides for treating herpes infections
11/02/1993US5258492 LHRH analogues with cytotoxic moieties at the sixth position
11/02/1993US5258391 For enhancing keratinization by topical application to nails, skin, lips and mucous membranes
11/02/1993US5258381 Inhibitors of glycosylation of proteins, antiaging agents, discoloration inhibition of teeth and storage stability of foods
11/02/1993US5258368 Polypeptides
11/02/1993US5258367 Administering to mammals
11/02/1993US5258362 Enzyme inhibitors, amides with oxetane ring
11/02/1993US5258324 Megakaryocyte colony stimulating factor and process for its preparation
11/02/1993US5258302 DNA for expression of aprotinin in methylotrophic yeast cells
11/02/1993US5258289 Specific cleavage of immunoglobulin E class peptides, allergy treatment
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993US5258180 For treating vascular conditions or disease
11/02/1993US5258178 Antibodies from cows milk which prevent gastritis
11/02/1993US5257901 Quick-priming centrifugal pump
11/02/1993CA1323851C Expression of human proapolipoprotein a-i
11/02/1993CA1323839C Methods for stimulating hair growth
10/1993
10/31/1993CA2095207A1 Use of inhibitors of plasminogen activators for the treatment of inflammations and wounds
10/28/1993WO1993021330A1 Human glutamine:fructose-6-phosphate amino-transferase
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021319A1 HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021312A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides
10/28/1993WO1993021308A1 Mutant cytokines having increased receptor affinity
10/28/1993WO1993021304A1 Method for the inhibition of the proliferation of cancer cells in a tumor
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021231A1 Adh water channel altering composition
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021225A1 Synthetic peptide, pulmonary surfactant containing the same, and remedy for respiratory distress syndrome
10/28/1993WO1993021224A1 Ultrapure human epidermal growth factor
10/28/1993WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
10/28/1993WO1993021222A1 Suppression of t-cell proliferation using peptide fragments of myelin basic protein
10/28/1993WO1993021221A1 Pulmonary surfactant protein fragments
10/28/1993WO1993021219A1 Endothelin antagonists ii
10/28/1993WO1993021216A1 Biologically active n-acylprolyldipeptides having antiamnestic, antihypoxic and anorexigenic effects
10/28/1993WO1993021215A1 Peptides having tachykinin antagonist activity
10/28/1993WO1993021214A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993WO1993021213A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993WO1993021212A1 Lactam dipeptides having hle inhibiting activity
10/28/1993WO1993021211A1 Amides having inhibiting activity on phospholipase a2, a process for the preparation thereof and pharmaceutical compositions containing them
10/28/1993WO1993021210A1 Pyrimidinyl acetamides as elastase inhibitors
10/28/1993WO1993021209A1 Lactam peptides having hle inhibiting activity
10/28/1993WO1993021208A1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments
10/28/1993WO1993021207A1 Process for making vancomycin
10/28/1993WO1993021176A1 Novel cyclic amino acids and derivatives thereof
10/28/1993WO1993020851A1 Methods for identifying agents useful in treating septicemia
1 ... 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 ... 3163